Published
BioVie President & CEO Cuong Do joins Natalie Stoberman from the Proactive studio to share the company's latest updates from clinical trials on Parkinson's Disease.
BioVie is a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease. For more information visit https://bioviepharma.com/
#proactiveinvestors #bioviepharma #NASDAQ #BIVI #pharma #pharmaceuticals #alzheimers #parkinsonsdisease #clinicaltrials
BioVie is a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease. For more information visit https://bioviepharma.com/
#proactiveinvestors #bioviepharma #NASDAQ #BIVI #pharma #pharmaceuticals #alzheimers #parkinsonsdisease #clinicaltrials
- Category
- Health
Be the first to comment
-
02:56
A world-first trial for Parkinson's disease
-
00:31
Pfizer begins third phase of clinical trial of Lyme disease vaccine
-
09:17
Phase II trial of XPro1595 for the treatment of Alzheimer’s disease
-
09:02
Trial of new treatment for Parkinson's disease | 7.30
-
03:53
Metabolic treatment of Parkinson's disease: What a clinical trial might look like.
-
01:22
Considering vascular pathologies when interpreting Alzheimer's disease trial results
-
03:38
BioVie shares latest updates on Alzheimer's and Parkinson's Disease clinical trials
-
04:42
Resverlogix Announces Patient Enrollment and Dosing in Phase 2b Trial for COVID-19 Treatment
-
02:58
Phase I trial of fetal striatal cell transplantation in Huntington’s disease
-
05:53
Roche's head of cardiovascular disease dissects GLP-1 drug trial results
-
03:19
Jowar Khichdi Recipe | Healthy & Yummy | Gluten Free Weight Loss Millet Recipes | Culinary Aromas
-
08:07
৭ দিনে যৌন ক্ষমতা বাড়ানোর কুরআনী চিকিৎসা/ Treatment of metal corrosion disease in Bangla
-
00:12
Healthy Lifestyle
